APIM Therapeutics AS
PrivateLast Round
Private Equity
May 18, 2021
Total Funding Raised
$540,000
Company Overview
APIM Therapeutics AS is a biotechnology company that develops first-in-class peptide therapeutics targeting PCNA to disrupt cellular stress responses and overcome cancer treatment resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APIM Therapeutics AS Comparables
Compare APIM Therapeutics AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RLL, LLC | 83% | |
| FoRx Therapeutics | 71% | |
| Artios Pharma | 66% |
APIM Therapeutics AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 18, 2021 | ||||
| VC Round | Dec 1, 2017 | ||||
| VC Round | Oct 17, 2012 | ||||
| Seed | Nov 10, 2011 | ||||
| Seed | Mar 21, 2011 | ||||
Seed | May 27, 2010 |
APIM Therapeutics AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Birk Venture | VC Round, Seed |
| Investinor | VC Round |
| Trond Mohn Research Foundation | VC Round |
| Sarsia Seed | Seed |
| Sarsia | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors grew 95% MoM.
- Jan 9, 2026
Monthly visitors grew 123% MoM, reaching 984.
APIM Therapeutics AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about APIM Therapeutics AS's valuation, stock price, and market status.
Is APIM Therapeutics AS a public or private company?
APIM Therapeutics AS is a private company.
What is the current stock price of APIM Therapeutics AS?
APIM Therapeutics AS is a private company with no public stock price. No recent secondary market data is available.
How much is APIM Therapeutics AS worth (valuation)?
Valuation information for APIM Therapeutics AS is not publicly available.
Can I buy APIM Therapeutics AS stock?
APIM Therapeutics AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was APIM Therapeutics AS's last funding round?
APIM Therapeutics AS's most recent funding round was Private Equity on May 18, 2021.
Who are the main investors in APIM Therapeutics AS?
Key investors in APIM Therapeutics AS include Birk Venture, Sarsia Seed.
Will APIM Therapeutics AS IPO soon?
No public IPO plans have been announced for APIM Therapeutics AS.
How can I track APIM Therapeutics AS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor APIM Therapeutics AS's secondary market activity and sign up for updates.